Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SLC6A3 anticorps (Internal Region)

SLC6A3 Reactivité: Humain WB, EIA Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN954827
  • Antigène Voir toutes SLC6A3 Anticorps
    SLC6A3 (Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3))
    Épitope
    • 16
    • 9
    • 7
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reactivité
    • 49
    • 38
    • 36
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 57
    • 5
    • 1
    • 1
    Chèvre
    Clonalité
    • 60
    • 4
    Polyclonal
    Conjugué
    • 38
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SLC6A3 est non-conjugé
    Application
    • 51
    • 26
    • 21
    • 15
    • 13
    • 13
    • 11
    • 11
    • 7
    • 7
    • 6
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Séquence
    C-QLTSSTLTNP RQSP
    Specificité
    Recognizes SLC6A3 / DAT
    Réactivité croisée (Details)
    Species reactivity (tested):Human.
    Purification
    Ammonium Sulphate Precipitation followed by antigen Affinity Chromatography using the immunizing peptide
    Immunogène
    Peptide with sequence from the internal region (near N Terminus) of the protein sequence according to NP_001035.1. Genename: SLC6A3
    Top Product
    Discover our top product SLC6A3 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Tris buffered saline, pH ~7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Wiers, Lohoff, Lee, Muench, Freeman, Zehra, Marenco, Lipska, Auluck, Feng, Sun, Goldman, Swanson, Wang, Volkow: "Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study." dans: The European journal of neuroscience, Vol. 48, Issue 3, pp. 1884-1895, (2018) (PubMed).

  • Antigène
    SLC6A3 (Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3))
    Autre désignation
    SLC6A3 / DAT (SLC6A3 Produits)
    Synonymes
    anticorps DAT, anticorps SLC6A3, anticorps Dat1, anticorps DAT1, anticorps PKDYS, anticorps solute carrier family 6 member 3, anticorps solute carrier family 6 (neurotransmitter transporter), member 3, anticorps Sodium-dependent dopamine transporter, anticorps solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, anticorps SLC6A3, anticorps slc6a3, anticorps dat-1, anticorps Slc6a3
    Sujet
    Plasmalemmal neurotransmitter transporters sequester synaptic and peri synaptic transmitter into presynaptic elements. The Dopamine Transporter (DAT) is responsible for the reaccumulation of dopamine after it has been released. Levels of DAT protein expression are altered by chronic drug administration. The activity of the DAT reuptake carrier is sodium dependent, and it is suspected to play a role in such neurologic and psychiatric disorders as Parkinson's disease, Tourette's disease, schizophrenia, and addiction. It is a 12 transmembrane domain transporter with the N and C terminal regions located within the cytoplasm.Synonyms: DA transporter, DAT1, Sodium-dependent dopamine transporter, Solute carrier family 6 member 3
    ID gène
    6531
    NCBI Accession
    NP_001035
    Pathways
    Dopaminergic Neurogenesis
Vous êtes ici:
Support technique